Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) Extension Study for Subjects Previously Enrolled in Triheptanoin Studies

NCT02214160 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
94
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Ultragenyx Pharmaceutical Inc